Xilio Therapeutics, Inc. (XLO)
NASDAQ·Healthcare·Biotechnology
$7.88
-3.67%
Mkt Cap $28.36M
Next Earnings
In 16 daysThu, May 14, 2026
EPS Estimate
-$0.66
1 analysts
Revenue Estimate
$8.52M
Last quarter: beat by +49.40% on EPS, +25.60% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$28.36M
P/E
—
Fwd P/E
—
P/S
1.05
Rev TTM
—
EPS TTM
-$0.42